However, compounded formulations sometimes include additional ingredients that can affect digestive tolerance
Eligibility typically includes individuals with a body mass index (BMI) of 30 or higher , or a BMI of 27 or higher with at least one weight-related health condition, such as type 2 diabetes, high blood pressure, or high cholesterol
Call 999 or go to your nearest A&E immediately if you experience: Severe abdominal pain with vomiting that does not settle this may indicate pancreatitis or a serious gallbladder problem Signs of a severe allergic reaction (anaphylaxis) including swelling of the face, lips, or throat, difficulty breathing, or a widespread rash Severe dehydration with inability to keep any fluids down Contact NHS 111 or seek urgent medical advice if you experience: Sudden pain in the upper right abdomen, fever, jaundice, pale stools, or dark urine possible signs of gallbladder disease Persistent vomiting or diarrhoea that is preventing adequate fluid intake Contact your GP or specialist if you experience: Persistent or troublesome nausea, vomiting, or abdominal discomfort that does not resolve with time Significant changes in mood, including low mood or anxiety, which may be associated with rapid weight loss or hormonal shifts Noticeable and sustained changes in libido or sexual function that are causing distress Irregular menstrual cycles or new hormonal symptoms Symptoms of hypoglycaemia shakiness, sweating, confusion, or palpitations particularly if you are also taking insulin or a sulfonylurea Any injection site reactions that worsen, become infected, or do not resolve Concerns about dehydration or reduced urine output following persistent gastrointestinal symptoms Changes in libido, whilst not confirmed as a direct side effect of retatrutide, are worth discussing with a GP if they are persistent, distressing, or accompanied by other symptoms
Managing and Minimizing Side Effects Taking a proactive approach to managing side effects can make a significant difference in a patients experience with GLP-1 medications
These are often listed as U-100 insulin syringes with an attached needle
In some cases, clinicians may choose this approach when rapid therapeutic benefit is needed, but it is always paired with careful monitoring because the risk of GI events is higher with faster dose increments
